Should I use a nitroglycerin patch that delivers 0.1 mg per hour for chronic tendinopathy when a 5 mg per 24‑hour patch is unavailable?

Nitroglycerin Patch Dosing for Chronic Tendinopathy

Do not use a 0.1 mg/hour (2.4 mg/24-hour) nitroglycerin patch for chronic tendinopathy when a 5 mg/24-hour patch is unavailable—the dose is too low to be effective based on the available evidence.

Evidence-Based Dosing for Tendinopathy

The research literature consistently demonstrates that effective transdermal nitroglycerin therapy for chronic tendinopathy requires 1.25–1.44 mg per 24 hours 1, 2, 3, 4, 5. Your proposed 0.1 mg/hour patch delivers only 2.4 mg per 24 hours, which is approximately double the proven therapeutic dose and may seem adequate, but the studies specifically used patches delivering around 5 mg/24 hours to achieve the target tissue concentration of 1.25–1.44 mg 1, 2.

Why the 0.1 mg/hr Patch Is Inadequate

• Proven effective dose range: Three high-quality randomized controlled trials used 1.25 mg/24 hours as the effective dose for Achilles and lateral epicondyle tendinopathy 2, 3, 5.
• One study used 1.44 mg/24 hours with similar positive outcomes 1.
• The 0.1 mg/hour patch delivers 2.4 mg/24 hours, which appears higher than the therapeutic target but represents the total drug content, not the delivered dose—transdermal patches typically deliver only 25–30% of their stated content through the skin 1, 2.
• A 5 mg/24-hour patch is specifically designed to deliver approximately 1.25 mg of active drug to tissues over 24 hours 5.

Clinical Outcomes with Proper Dosing

When the correct dose is used, the evidence shows:

• Significant pain reduction during activities of daily living in chronic tendinopathy (odds ratio 4.44,95% CI 2.34–8.40) 3, 4.
• 78% of tendons became asymptomatic at 6 months with 1.25 mg/24-hour dosing plus rehabilitation, compared to 49% with placebo 5.
• Reduced pain with activity at 12 weeks (p=0.02) and 24 weeks (p=0.03) 5.
• Improved functional measures including ankle plantar flexor work and hop test performance 5.
• Enhanced tendon strength in the chronic phase (Level 1 evidence) 4.

What to Do When 5 mg/24-Hour Patches Are Unavailable

Option 1: Wait for Proper Dosing

• Delay treatment until you can obtain 5 mg/24-hour patches, as subtherapeutic dosing will likely fail and may discourage the patient from future evidence-based therapy 1, 2, 4.

Option 2: Alternative Evidence-Based Treatments

• Eccentric strengthening exercises are the cornerstone of tendinopathy management and have Level B evidence for effectiveness 6, 7.
• Relative rest and activity modification prevent further damage while promoting healing 6.
• Cryotherapy provides acute pain relief; apply melting ice water through a wet towel for 10-minute periods 6.
• Short-term NSAIDs (≤2 weeks) for pain relief, though they do not alter long-term outcomes 6.
• Extracorporeal shock wave therapy is safe and effective but expensive 6.

Option 3: Refer for Alternative Interventions

• Local corticosteroid injection may provide superior short-term pain relief compared to exercise alone, though it does not improve long-term outcomes 6.
• Surgery should be reserved for patients who fail 3–6 months of conservative therapy 6.

Critical Contraindications to Nitroglycerin

Even if you obtain the correct dose, verify the patient has not used phosphodiesterase-5 inhibitors:

• Within 12 hours of avanafil 8.
• Within 24 hours of sildenafil or vardenafil 9, 8, 10.
• Within 48 hours of tadalafil 9, 8.
• Concurrent use can cause profound hypotension, myocardial infarction, or death 8.

Common Adverse Effects at Therapeutic Dosing

• Headache is the most frequent side effect, occurring in 1–9 patients per study and causing treatment discontinuation in some cases 1, 2, 3, 4, 5.
• Contact dermatitis occurs but is not significantly more common than placebo 3, 4.
• The incidence of headache is increased with nitroglycerin (odds ratio 1.73,95% CI 1.01–2.97) 3.

Application Protocol When Using Correct Dosing

• Apply the patch to the area of maximal tenderness once daily 2.
• Duration of therapy: 12–24 weeks based on the evidence 1, 3, 4, 5.
• Combine with eccentric exercise rehabilitation for optimal outcomes—nitroglycerin alone is less effective than when combined with structured tendon loading 1, 3.
• Most recent high-quality evidence (2024) showed that GTN ointment plus eccentric exercise was not superior to placebo plus eccentric exercise in a 76-patient trial, suggesting the benefit may be modest or that eccentric exercise is the primary driver of improvement 11.

Bottom Line Algorithm

1. Do not use the 0.1 mg/hour patch—it delivers insufficient active drug to tissues 1, 2, 4, 5.
2. Initiate eccentric strengthening exercises immediately as first-line therapy 6, 7.
3. Obtain 5 mg/24-hour nitroglycerin patches if you wish to add topical nitrate therapy 1, 2, 5.
4. Screen for PDE-5 inhibitor use before prescribing any nitrate 9, 8.
5. Warn the patient about headache as the most common side effect 1, 3, 4.
6. Reassess at 12 weeks; if no improvement, consider corticosteroid injection or referral for advanced interventions 6.